Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,630
Closed -$80.7K 2030
2024
Q4
$80.7K Buy
+2,630
New +$87.4K ﹤0.01% 1985
2020
Q4
Sell
-33,200
Closed -$1.09M 898
2020
Q3
$1.09M Buy
33,200
+13,500
+69% +$572K 0.01% 769
2020
Q2
$893K Buy
+19,700
New +$1.01M 0.01% 678

Other funds holding ATEX

Steven Cohen's ATEX Position: Q1 2025 in Review

Steven Cohen sold out of Anterix (ATEX) in Q1 2025, closing a stake of 2,630 shares — an estimated $80.7K sold.

Steven Cohen first reported a position in ATEX in Q2 2020 and held it in 3 quarters. The position peaked at $1.09M in Q3 2020. 128 funds tracked by Wall St. Rank hold ATEX as of Q1 2025.

  • Steven Cohen reported no remaining Anterix position as of Q1 2025 after selling out during the quarter.
  • Steven Cohen sold 2,630 Anterix shares in Q1 2025, an estimated $80.7K.
  • Steven Cohen first reported a position in Anterix in Q2 2020 and held it in 3 quarters.
  • Steven Cohen's Anterix position peaked at $1.09M in Q3 2020.
  • 128 funds tracked by Wall St. Rank held Anterix as of Q1 2025.

Based on Point72 Asset Management's 13F filing for Q1 2025, filed 15 May 2025.